Education
About Us
Working with TipRanks
Follow Us
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
Atea Pharmaceuticals (AVIR) Ownership Overview
9.30% Insiders
14.02% Mutual Funds
21.28% Other Institutional Investors
10.88% ETFs
44.52% Public Companies and Individual Investors
The ownership structure of Atea Pharmaceuticals (AVIR) stock is a mix of institutional, retail, and individual investors. Approximately 46.18% of the company’s stock is owned by Institutional Investors, 9.30% is owned by Insiders, and 44.52% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 17, 2025 | xxxxxxxxxxxxx | $81450 | |
Dec 12, 2024 | xxxxxxxxxxxxx | $1021281 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $49938 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,166,965 | Insider | 7.21% | 19,795,958 | |
| 4,253,623 | Institution | 4.97% | 13,654,130 | |
| 3,545,502 | Institution | 4.14% | 11,381,061 | |
| 3,444,012 | Institution | 4.02% | 11,055,279 | |
| 1,783,614 | Institution | 2.08% | 5,725,401 | |
| 842,943 | Institution | 0.98% | 2,705,847 | |
| 810,776 | Institution | 0.95% | 2,602,591 | |
| 771,219 | Institution | 0.90% | 2,475,613 | |
| 717,307 | Insider | 0.84% | 2,302,555 | |
| 549,380 | Institution | 0.64% | 1,763,510 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,545,502 | Institution | 4.14% | 11,381,061 | |
| 1,783,614 | Institution | 2.08% | 5,725,401 | |
| 842,943 | Institution | 0.98% | 2,705,847 | |
| 810,776 | Institution | 0.95% | 2,602,591 | |
| 771,219 | Institution | 0.90% | 2,475,613 | |
| 549,380 | Institution | 0.64% | 1,763,510 | |
| 502,608 | Institution | 0.59% | 1,613,372 | |
| 408,915 | Institution | 0.48% | 1,312,617 | |
| 407,002 | Institution | 0.48% | 1,306,476 | |
| 342,681 | Institution | 0.40% | 1,100,006 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,428,241 | Institution | 2.84% | 7,211,876 | |
| 1,891,083 | Institution | 2.21% | 6,032,555 | |
| 1,211,224 | Institution | 1.42% | 3,597,335 | |
| 680,166 | Institution | 0.79% | 2,169,730 | |
| 444,827 | Institution | 0.52% | 1,418,998 | |
| 386,694 | Institution | 0.45% | 1,148,481 | |
| 361,474 | Institution | 0.42% | 1,153,102 | |
| 277,211 | Institution | 0.32% | 875,987 | |
| 173,303 | Institution | 0.20% | 552,837 | |
| 167,431 | Institution | 0.20% | 497,270 |
FAQ
Who Owns Atea Pharmaceuticals (AVIR)?
According to the latest TipRanks data, approximately 21.28% of the company's stock is held by institutional investors, 9.30% is held by insiders, and 44.52% is held by retail investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.28% of Atea Pharmaceuticals (AVIR) stock is held by institutional investors.
What percentage of Atea Pharmaceuticals (AVIR) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.52% of Atea Pharmaceuticals (AVIR) stock is held by retail investors.
Who owns the most shares of Atea Pharmaceuticals (AVIR)?
Jean-Pierre Sommadossi owns the most shares of Atea Pharmaceuticals (AVIR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.